Category: pharmacological
Aliases: GW-501516, GW-1516, GW501516
PPARδ agonist — activates fatty-acid oxidation programs in skeletal muscle, increasing endurance capacity. NOT a SARM despite being grouped with them. GSK halted development after rodent carcinogenicity at multiple sites; banned by WADA.
PO: 24h